Illustrative image – not actual.The Maharashtra government has cleared a biotechnology policy that offers several financial incentives and tax benefits to companies setting up biotech units in the state.
The incentives include a lower tax rate under the value added tax (VAT) regime, twice the existing floor space index (FSI) for biotech units, exemption from stamp duty and registration fee and 30 per cent of the fixed capital investment.
The highlights include:
·
Biotech units can be set up in all regions of the state and would be
eligible for incentives available in the state's second least developed
regions.
·
Units set up in regions where development has already occurred (B, C
and D) regions would be eligible for a second tier of incentives. These
incentives include capital subsidy for small scale biotechnology units and
refund of octroi and similar levies.
·
Twice the admissible FSI would be made admissible for units in parks
promoted by the Maharashtra Industrial Development Corporation (MIDC) and other
public bodies and other yet-to-be-designated locations.
·
The original draft policy offered the sales tax floor rate for the next
five years for biotech products. But with the VAT regime - to be implemented by
1 April 2002 - the government has decided to offer a very liberalised scheme
under this regime, which will be on par with the other incentives offered to
biotech units set up in the state.
·
New units and the subsequent expansion of existing units will be
exempted from payment of stamp duty and registration fees in the developing and
backward regions of the state. In other areas, such exemption would be extended
to units in biotech parks promoted by public bodies. In private parks, 50 per
cent of such stamp duty and registration fees would be waived. In addition,
only 10 per cent of the admissible stamp duty would be payable on property
transactions resulting from amalgamation of biotech companies.
- The government will encourage the setting up of world class centres of excellence which will cover all aspects of cutting edge R&D in the emerging areas of life sciences and technology. To facilitate this, the state will offer land at concessional rates to such centres of excellence in the area of biotechnology, and norms will be set to define such centres that would be subject to scrutiny and approval on an individual basis.
·
The policy proposes to offer infrastructural support to the biotechnology
industry. This includes setting up of new biotech parks concentrating on
pharmaceuticals and agriculture at Pune and Aurangabad, respectively. Other
such park sites would be selected subsequently. Apart from the facilities
common to any technology park, the biotech parks will offer GMP facilities in
conformity with US Food and Drug Administration norms.
·
A business facilitation centre (BFC) will offer services to the clients
of the park to create a hassle-free environment. These include a cell for
assisting in regulatory and customs clearances and to allow an interface with
government bodies; handholding services to entrepreneurs in getting electricity
and telephone connections etc; technology transfer and access services;
commercialisation services, networking with research institutions; information
and support on intellectual property protection. The BFC will provide
connectivity with academic and research institutions for providing necessary
human resource development base, physical infrastructure such as quality power,
telecommunication, connectivity, adequate bandwidth and reliable water supply.
·
The government would make available land for building residential
complexes for scientists and biotechnology professionals complete with
schooling and recreational facilities.
·
A biotechnology resource centre would be set up for certification of
products after testing them intensively. An experimental animal facility
meeting ethical, legal and safety standards would also be set up. The civil
construction work for these facilities would depend on contributions from
industry and charitable institutions. The government is seeking active
participation from NRI, academic and other organisations located abroad for
setting up and running these facilities.
·
The biotech parks and the resource centre would evolve new patterns of
collaboration between research scientists, industry personnel, extension
workers, farming community and consumers for wider dissemination and better
understanding of costs and benefits of biotechnology.
·
On the issue of intellectual property rights (IPR), which is an
important issue in the industry as well as the research community, an awareness
campaign would be undertaken to educate users and consumers. A special manpower
training programme would be developed at the University of Pune, which has
already pioneered the forays into IPR by setting up the first CSIR chair in
IPR. A special course would be introduced at the postgraduate level in the HRD
programmes so as to cover the various aspects of IPR. The curricula for the law
faculty would witness the necessary revision and new subjects would be added to
incorporate patent law and international IPR-related law courses on high
priority.
·
The policy notes that unlike other industries, biotech companies are
dependent on highly skilled personnel at all levels of operations. The centres
supplying such manpower at present would therefore have to be strengthened and
diversified; otherwise certain important requirements may remain unmet.
